Primary HIV Infection Flashcards

1
Q

How many of patients infected with HIV are infected with a single quasispecies?

A

80%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What increases the risk of being infected with multiple HIV quasispecies?

A

IVDU is highest group, MSM is higher than hetersexuals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How many days after initial inoculation is virus found in the regional lymph nodes?

A

3 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How long after initiail inoculation does it take to find HIV in cells?

A

2 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How long does it take HIV to become disseminated across the body?

A

25 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What happens to CD$ cells with active viral replication?

A

they die

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What happens to the lymph nodes in HIV infection?

A

uncontrolled viral replication leads to lymph nodes architecture desctruction and prevents immmune priming

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What does a larger HIV reservoir mean for a patient?

A

accelerates clinical progression and predicts time to viral rebound

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What does point of care HIV testing measure?

A

antibody only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the 4th generation lab test for HIV

A

antigen (p24) and antibody

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is p24?

A

capsid protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What does the WEstern blot HIV test test for?

A

antibodies against bands of different antigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the Fiebig staging ssytem for acute HIV?

A

determines when you were HIV infected based on your positive test results

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does the Fiebig staging system allow you to do?

A

the likelihood of whether or not have HIV- e.g if tests that you would expect to be positive at 2 weeks are negative- unlikely

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the avergae rate of CD4 decline without ARt?

A

67 cells/year

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are htegenetic factors most strongly associated wti hnon-progressive infection?

A

HLA class I alleles esp. HLA-B5701

17
Q

What cellular responses are associated with non-progressive infection?

A

CD4 and CD8 T cell repsonses with polyfunctional profile

18
Q

Why are many age-associated diseases such as CVS disease or cancer thorugh to be more common in treated HIV disease than in theri HVI-negative couterparts?

A

chronic inflammation is thought to underlie much of this

19
Q

What factors cause persistent inflammation during ARt?

A

HIV production and replication; ART toxicitiy; lipodystrophy; CMV and other copathogens; loss of regulatory cells

20
Q

What is the eclipse phase of acute HIV infection?

A

HIV is replicating in the mucosa; submucosa nad draining lymphoreticular tissues and cannot be detected in the plasma

21
Q

How long can the eclipse phase last?

A

7-21 days

22
Q

What type of epithlelium is foudn in the rectum and endocervix?

A

columnar

23
Q

What type of epithelium is found in the vagina and ectocervix?

A

stratified squamous

24
Q

What cells does HIV first infect in the vagina; ectocervix and penile foreskin?

A

langerhan cells and CD4 T cells

25
Q

Which lymphoreticular system does HIV replication converge upon within a few days

A

GALT

26
Q

What is the first signal of an immune response to HIV infection in the blood?

A

appearance of acute-phase reactants incl. alpha1 antitrypsin and amyloid A

27
Q

Which cytokine does the steep rise in the HIV viral load coincide with a large burst of?

A

IFN-a and IL-15

28
Q

Describe the initial antibody response to HIV?

A

its to the viral envelope; is non-neutralising and doesn’t select for viral escape

29
Q

When are the first neutralising antibodies to the transmitted founder virus found?

A

3 or more months after infection

30
Q

Why are HLA types HLA-B27 and HLA-B57 associated with better viral control?

A

present highly conserved parts ofh te virus to T cells so that the virus can escape immune control only at the cost of replicative fitness

31
Q

What have cervicovaginal transmsiions studies with SIV implicated as the earliest target cells of SIV infection?

A

CCR5 and CD4 T cells in the lamina propria of the endocervix

32
Q

What has been a challenge with developing SHIV?

A

circulating HIV variants don’t use the macaque CD4 receptor for entry so they have to use adapted HIV envelope variants to permi entry using this receptor

33
Q

What illustrates the difficulties with acaque studies in humans?

A

there are differences in early events of infection between SIV and SHIV which shows there amy be unique features to each virus/host interaction and there is no way to know which findings translate to huamns

34
Q

What is SHIV?

A

a chimera whose genome is a combo of SIV and HIV- ancode HiV envelope

35
Q

What are risk factors for the transmission by more than one genetic variant?

A

STIs and hormonal contraceptives

36
Q

What suggests that transmission resets the virus population to the less pathogenic transmissable form?

A

there has not been a trend of increased virulence over the course of the HIV epidemic; trnamistted viruses are not very similar to donor sequences near the time of transmission but to the donor seuences earlier in infection- archived variant?

37
Q

What are the differences between viruses seen at transmission vs chronic infection?

A

at transmission have less glycosylation and hsorter variable loops whereas viruses with more glyosylation dominate in chornic infection as can escape neutralising antibodies ; CCR5 viruses are favoured; less sensitive to inhibition by type I IFNs